Literature DB >> 19777535

The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain.

Linda F Brown1, Kurt Kroenke, Dale E Theobald, Jingwei Wu, Wanzhu Tu.   

Abstract

OBJECTIVES: Depression is known to be a major problem in cancer patients, and evidence is emerging about the importance of anxiety. Because the disorders are highly comorbid, we examined the relationship of anxiety and depression with health-related quality of life (HRQL) in cancer patients.
METHODS: Sample included 405 adult oncology patients participating in a randomized controlled trial of telecare management for pain and depression. This secondary cross-sectional analysis of baseline data examined independent and additive effects of anxiety and depression on HRQL, disability, and somatic symptom severity.
RESULTS: In 397 patients who screened positive for either pain or depression or both, 135 had comorbid anxiety and depression, 174 had depression but not anxiety, and 88 had neither. Differences existed across all nonphysical HRQL domains and were more pronounced incrementally across the three groups in the expected direction. In GLM modeling, anxiety and depression were each associated with all the domains when modeled separately (p<0.0001). When modeled together, anxiety and depression had independent and additive effects on the mental health domains of HRQL and on somatic symptom burden. In other domains (vitality, perceived disability, overall quality of life, and general health perceptions), only depression had an effect.
CONCLUSION: Anxiety and depression have strong and independent associations with mental health domains and somatic symptom burden in cancer patients. However, depression has a more pervasive association with multiple other domains of HRQL. Paying attention to both anxiety and depression may be particularly important when addressing mental health needs and somatic symptom distress. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19777535      PMCID: PMC2888919          DOI: 10.1002/pon.1627

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  23 in total

1.  Management of cancer symptoms: pain, depression, and fatigue.

Authors:  D Carr; L Goudas; D Lawrence; W Pirl; J Lau; D DeVine; B Kupelnick; K Miller
Journal:  Evid Rep Technol Assess (Summ)       Date:  2002-07

2.  Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

Authors:  Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

3.  Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.

Authors:  K Kroenke; S L West; R Swindle; A Gilsenan; G J Eckert; R Dolor; P Stang; X H Zhou; R Hays; M Weinberger
Journal:  JAMA       Date:  2001-12-19       Impact factor: 56.272

4.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

5.  A three-component model for reengineering systems for the treatment of depression in primary care.

Authors:  Thomas E Oxman; Allen J Dietrich; John W Williams; Kurt Kroenke
Journal:  Psychosomatics       Date:  2002 Nov-Dec       Impact factor: 2.386

Review 6.  Depression and cancer: mechanisms and disease progression.

Authors:  David Spiegel; Janine Giese-Davis
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 7.  Depression and pain comorbidity: a literature review.

Authors:  Matthew J Bair; Rebecca L Robinson; Wayne Katon; Kurt Kroenke
Journal:  Arch Intern Med       Date:  2003-11-10

8.  Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life.

Authors:  D Stark; M Kiely; A Smith; G Velikova; A House; P Selby
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

9.  The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants.

Authors:  Kurt Kroenke; Dale Theobald; Kelli Norton; Rebecca Sanders; Susan Schlundt; Stephanie McCalley; Pamela Harvey; Karen Iseminger; Gwendolyn Morrison; Janet S Carpenter; Dawana Stubbs; Rakeva Jacks; Caroline Carney-Doebbeling; Jingwei Wu; Wanzhu Tu
Journal:  Gen Hosp Psychiatry       Date:  2009-04-05       Impact factor: 3.238

10.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

View more
  74 in total

1.  The role of trait emotional intelligence in the diagnostic cancer pathway.

Authors:  Samuel G Smith; K V Petrides; James S A Green; Nick Sevdalis
Journal:  Support Care Cancer       Date:  2012-03-09       Impact factor: 3.603

2.  Health care expenditures associated with depression in adults with cancer.

Authors:  Xiaoyun Pan; Usha Sambamoorthi
Journal:  J Community Support Oncol       Date:  2015-07

3.  Depressive symptoms in older long-term colorectal cancer survivors: a population-based analysis using the SEER-Medicare healthcare outcomes survey.

Authors:  Clancy J Clark; Nora F Fino; Jia Hao Liang; David Hiller; Jaime Bohl
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

Review 4.  A meta-analysis of the relationship between social constraints and distress in cancer patients.

Authors:  Rebecca N Adams; Joseph G Winger; Catherine E Mosher
Journal:  J Behav Med       Date:  2014-09-28

5.  Depression and anxiety in patients with heart disease and/or cancer based on the National Health Interview Survey.

Authors:  Mina M Benjamin; Robert Bossarte; Avirup Guha; Mahek Shah; Brijesh Patel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-19

6.  Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

Authors:  Yi-Ting Chou; Aaron N Winn; Donald L Rosenstein; Stacie B Dusetzina
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03-19       Impact factor: 2.890

7.  How are spousal depressed mood, distress, and quality of life associated with risk of depressed mood in cancer survivors? Longitudinal findings from a national sample.

Authors:  Kristin Litzelman; K Robin Yabroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06       Impact factor: 4.254

8.  Identification of distinct depressive symptom trajectories in women following surgery for breast cancer.

Authors:  Laura B Dunn; Bruce A Cooper; John Neuhaus; Claudia West; Steven Paul; Bradley Aouizerat; Gary Abrams; Janet Edrington; Debby Hamolsky; Christine Miaskowski
Journal:  Health Psychol       Date:  2011-07-04       Impact factor: 4.267

9.  Trajectory and predictors of quality of life during the dying process: roles of perceived sense of burden to others and posttraumatic growth.

Authors:  Siew Tzuh Tang; Wen-Cheng Chang; Jen-Shi Chen; Po-Jung Su; Chia-Hsun Hsieh; Wen-Chi Chou
Journal:  Support Care Cancer       Date:  2014-05-28       Impact factor: 3.603

10.  Long-term fear of recurrence in young breast cancer survivors and partners.

Authors:  Andrea A Cohee; Rebecca N Adams; Shelley A Johns; Diane Von Ah; Kathleen Zoppi; Betsy Fife; Patrick O Monahan; Timothy Stump; David Cella; Victoria L Champion
Journal:  Psychooncology       Date:  2015-10-21       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.